BioCardia Inc.

3.35-0.2300-6.42%Vol 181.62K1Y Perf 40.58%
Sep 24th, 2021 16:00 DELAYED
BID3.25 ASK3.50
Open3.50 Previous Close3.58
Pre-Market- After-Market-
 - -  - -%
Target Price
11.00 
Analyst Rating
Strong Buy 1.00
Potential %
228.36 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★+     48.92
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★+     48.44
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
21.52 
Earnings Rating
Market Cap56.52M 
Earnings Date
9th Nov 2021
Alpha-0.02 Standard Deviation0.21
Beta1.30 

Today's Price Range

3.253.50

52W Range

1.918.60

5 Year PE Ratio Range

-2.70915.40

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Week
7.72%
1 Month
13.56%
3 Months
-26.37%
6 Months
-22.99%
1 Year
40.58%
3 Years
-85.35%
5 Years
-73.03%
10 Years
-70.46%

TickerPriceChg.Chg.%
BCDA3.35-0.2300-6.42
AAPL146.920.09000.06
GOOG2 852.6616.13000.57
MSFT299.35-0.2100-0.07
XOM57.590.51000.89
WFC47.920.12000.25
JNJ164.36-0.5000-0.30
FB352.967.00002.02
GE103.800.84000.82
JPM163.041.86001.15
Financial StrengthValueIndustryS&P 500US Markets
4.30
4.30
0.09
0.02
-6 993.60
Leverage Ratio 1.30
ProfitabilityValueIndustryS&P 500US Markets
100.00
-6 809.70
-6 777.90
-3 803.30
-
RevenueValueIndustryS&P 500US Markets
195.00K
0.01
-36.16
-18.60
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.21-0.204.76
Q01 2021-0.21-0.1814.29
Q04 2020-0.31-0.1648.39
Q03 2020-0.28-0.30-7.14
Q02 2020-0.25-0.46-84.00
Q01 2020-0.32-0.67-109.38
Q04 2019--0.51-
Q03 2019-0.43-0.55-27.91
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date9th Nov 2021
Estimated EPS Next Report-0.23
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume181.62K
Shares Outstanding16.87M
Shares Float14.25M
Trades Count879
Dollar Volume758.19K
Avg. Volume188.45K
Avg. Weekly Volume1.25M
Avg. Monthly Volume356.25K
Avg. Quarterly Volume145.89K

BioCardia Inc. (NASDAQ: BCDA) stock closed at 3.35 per share at the end of the most recent trading day (a -6.42% change compared to the prior day closing price) with a volume of 182.23K shares and market capitalization of 56.52M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 24 people. BioCardia Inc. CEO is Peter Altman.

The one-year performance of BioCardia Inc. stock is 40.58%, while year-to-date (YTD) performance is -3.18%. BCDA stock has a five-year performance of -73.03%. Its 52-week range is between 1.91 and 8.6, which gives BCDA stock a 52-week price range ratio of 21.52%

BioCardia Inc. currently has a PE ratio of -3.70, a price-to-book (PB) ratio of 3.35, a price-to-sale (PS) ratio of 259.56, a price to cashflow ratio of 26.20, a PEG ratio of 2.32, a ROA of -78.03%, a ROC of -110.50% and a ROE of -113.78%. The company’s profit margin is -%, its EBITDA margin is -6 777.90%, and its revenue ttm is $195.00 Thousand , which makes it $0.01 revenue per share.

Of the last four earnings reports from BioCardia Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.23 for the next earnings report. BioCardia Inc.’s next earnings report date is 09th Nov 2021.

The consensus rating of Wall Street analysts for BioCardia Inc. is Strong Buy (1), with a target price of $11, which is +228.36% compared to the current price. The earnings rating for BioCardia Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BioCardia Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

BioCardia Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 19.80, ATR14 : 0.28, CCI20 : 136.44, Chaikin Money Flow : 0.15, MACD : 0.04, Money Flow Index : 92.36, ROC : 9.12, RSI : 56.69, STOCH (14,3) : 48.74, STOCH RSI : 0.64, UO : 56.45, Williams %R : -51.26), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BioCardia Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

BioCardia Inc.

BioCardia Inc is a clinical stage regenerative medicine company. It is developing therapeutics for cardiovascular diseases with large unmet medical needs. The company is developing comprehensive biotherapeutic candidates for cardiac regenerative medicine namely CardiAMP and CardiALLO, with a focus on heart failure resulting from a heart attack.

CEO: Peter Altman

Telephone: +1 650 226-0120

Address: 125 Shoreway Road, San Carlos 94070, CA, US

Number of employees: 24

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

71%29%

Bearish Bullish

56%44%

Bearish Bullish

57%43%

News

Stocktwits